BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32308758)

  • 1. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.
    Fernandes E; Sores J; Cotton S; Peixoto A; Ferreira D; Freitas R; Reis CA; Santos LL; Ferreira JA
    Theranostics; 2020; 10(11):4903-4928. PubMed ID: 32308758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
    Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Ferreira JA; Magalhães A; Gomes J; Peixoto A; Gaiteiro C; Fernandes E; Santos LL; Reis CA
    Cancer Lett; 2017 Feb; 387():32-45. PubMed ID: 26828132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen carrying SLe
    Gomes C; Almeida A; Barreira A; Calheiros J; Pinto F; Abrantes R; Costa A; Polonia A; Campos D; Osório H; Sousa H; Pinto-de-Sousa J; Kolarich D; Reis CA
    Theranostics; 2019; 9(24):7431-7446. PubMed ID: 31695778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer.
    Peixoto A; Ferreira D; Azevedo R; Freitas R; Fernandes E; Relvas-Santos M; Gaiteiro C; Soares J; Cotton S; Teixeira B; Paulo P; Lima L; Palmeira C; Martins G; Oliveira MJ; Silva AMN; Santos LL; Ferreira JA
    J Exp Clin Cancer Res; 2021 Jun; 40(1):191. PubMed ID: 34108014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral response against sialyl-Le(a) glycosylated protein species in esophageal cancer: Insights for immunoproteomic studies.
    Fernandes E; Peixoto A; Neves M; Afonso LP; Santos LL; Ferreira JA
    Electrophoresis; 2015 Dec; 36(23):2902-7. PubMed ID: 26333169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
    Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.
    Cotton S; Azevedo R; Gaiteiro C; Ferreira D; Lima L; Peixoto A; Fernandes E; Neves M; Neves D; Amaro T; Cruz R; Tavares A; Rangel M; Silva AMN; Santos LL; Ferreira JA
    Mol Oncol; 2017 Aug; 11(8):895-912. PubMed ID: 28156048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico approaches for unveiling novel glycobiomarkers in cancer.
    Azevedo R; Silva AMN; Reis CA; Santos LL; Ferreira JA
    J Proteomics; 2018 Jan; 171():95-106. PubMed ID: 28782717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
    Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
    N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics protocols in glycomics and glycoproteomics.
    Tang H; Mayampurath A; Yu CY; Mechref Y
    Curr Protoc Protein Sci; 2014 Apr; 76():2.15.1-2.15.7. PubMed ID: 24692013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
    Thaysen-Andersen M; Packer NH
    Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycobiomarkers by glycoproteomics and glycan profiling (glycomics): emergence of functionality.
    Gabius HJ
    Biochem Soc Trans; 2011 Jan; 39(1):399-405. PubMed ID: 21265812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.
    Kori M; Aydin B; Gulfidan G; Beklen H; Kelesoglu N; Caliskan Iscan A; Turanli B; Erzik C; Karademir B; Arga KY
    OMICS; 2021 Mar; 25(3):139-168. PubMed ID: 33404348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in gastric mucin with malignant transformation: novel pathway for mucin synthesis.
    Yamashita Y; Chung YS; Horie R; Kannagi R; Sowa M
    J Natl Cancer Inst; 1995 Mar; 87(6):441-6. PubMed ID: 7532228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of carbohydrate antigens, sialyl Lewis-x and sialyl Lewis-a in gastrointestinal cancer].
    Nakamori S; Arai I; Okamura S; Imaoka S; Furukawa H; Kabuto T; Ishikawa O; Sasaki Y; Kameyama M; Iwanaga T
    Nihon Geka Gakkai Zasshi; 1996 Feb; 97(2):165-71. PubMed ID: 8632746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
    Lima L; Neves M; Oliveira MI; Dieguez L; Freitas R; Azevedo R; Gaiteiro C; Soares J; Ferreira D; Peixoto A; Fernandes E; Montezuma D; Tavares A; Ribeiro R; Castro A; Oliveira M; Fraga A; Reis CA; Santos LL; Ferreira JA
    Urol Oncol; 2017 Dec; 35(12):675.e1-675.e8. PubMed ID: 28911924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
    Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
    J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust Glycoproteomics Platform Reveals a Tetra-Antennary Site-Specific Glycan Capping with Sialyl-Lewis Antigen for Early Detection of Gastric Cancer.
    Liu L; Liu L; Wang Y; Fang Z; Bian Y; Zhang W; Wang Z; Gao X; Zhao C; Tian M; Liu X; Qin H; Guo Z; Liang X; Dong M; Nie Y; Ye M
    Adv Sci (Weinh); 2024 Mar; 11(9):e2306955. PubMed ID: 38084450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoproteins and glycoproteomics in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.